AH Bio Fund III-Q, L.P. — Form D/A
AH Bio Fund III-Q, L.P. of MENLO PARK, CA, a pooled investment fund, filed a Form D amendment with the SEC on 2020-03-03. The offering totals $75.0M, of which $75.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2020-03-03
- Form: D/A
- Accession: 0001799479-20-000002
- Industry: Pooled Investment Fund
- Exemptions: 06c, 3C, 3C.7
- Total offering: $75.0M
- Amount sold: $75.0M
- Investors: 40
- Date of first sale: 2020-01-31
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-360599
Issuer
- Name: AH Bio Fund III-Q, L.P.
- CIK: 0001799479
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 2865 SAND HILL ROAD, SUITE 101, MENLO PARK, CA, 94025
- Phone: (650) 798-5800
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Marc Andreessen | Executive Officer | Menlo Park, CA |
| Ben Horowitz | Executive Officer | Menlo Park, CA |
Other filings by this issuer (1)
More